Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Conditionally immortalized human podocyte cell lines established from urine.

Sakairi T, Abe Y, Kajiyama H, Bartlett LD, Howard LV, Jat PS, Kopp JB.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F557-67. doi: 10.1152/ajprenal.00509.2009. Epub 2009 Dec 2.

2.

TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.

Sakairi T, Abe Y, Kopp JB.

Nephrol Dial Transplant. 2011 Sep;26(9):2746-52. doi: 10.1093/ndt/gfr061. Epub 2011 Mar 4.

3.

Marker expression, behaviors, and responses vary in different lines of conditionally immortalized cultured podocytes.

Chittiprol S, Chen P, Petrovic-Djergovic D, Eichler T, Ransom RF.

Am J Physiol Renal Physiol. 2011 Sep;301(3):F660-71. doi: 10.1152/ajprenal.00234.2011. Epub 2011 Jun 1.

4.

Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.

Perez-Hernandez J, Olivares MD, Forner MJ, Chaves FJ, Cortes R, Redon J.

Nephrol Dial Transplant. 2016 May;31(5):780-9. doi: 10.1093/ndt/gfw002. Epub 2016 Feb 29.

PMID:
26932688
5.

The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.

Sakamoto K, Ueno T, Kobayashi N, Hara S, Takashima Y, Pastan I, Matsusaka T, Nagata M.

Am J Physiol Renal Physiol. 2014 Jan 1;306(1):F98-F104. doi: 10.1152/ajprenal.00228.2013. Epub 2013 Oct 23.

6.

Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.

Lioudaki E, Stylianou KG, Petrakis I, Kokologiannakis G, Passam A, Mikhailidis DP, Daphnis EK, Ganotakis ES.

Nephron. 2015;131(1):34-42. doi: 10.1159/000438493. Epub 2015 Sep 5.

PMID:
26340089
7.

Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases.

Achenbach J, Mengel M, Tossidou I, Peters I, Park JK, Haubitz M, Ehrich JH, Haller H, Schiffer M.

Nephrol Dial Transplant. 2008 Oct;23(10):3138-45. doi: 10.1093/ndt/gfn235. Epub 2008 May 5.

PMID:
18458033
8.

Urine podocyte mRNAs mark progression of renal disease.

Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M, Chang JW, Wiggins JE, Lienczewski C, Kretzler M, Wiggins RC.

J Am Soc Nephrol. 2009 May;20(5):1041-52. doi: 10.1681/ASN.2007121328. Epub 2009 Apr 23.

9.

Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis.

Szeto CC, Wang G, Chow KM, Lai FM, Ma TK, Kwan BC, Luk CC, Li PK.

Clin Nephrol. 2015 Oct;84(4):198-205. doi: 10.5414/CN108607.

PMID:
26308082
10.

Cell-cell contact regulates gene expression in CDK4-transformed mouse podocytes.

Sakairi T, Abe Y, Jat PS, Kopp JB.

Am J Physiol Renal Physiol. 2010 Oct;299(4):F802-9. doi: 10.1152/ajprenal.00205.2010. Epub 2010 Jul 28.

11.

Cystinosin deficiency causes podocyte damage and loss associated with increased cell motility.

Ivanova EA, Arcolino FO, Elmonem MA, Rastaldi MP, Giardino L, Cornelissen EM, van den Heuvel LP, Levtchenko EN.

Kidney Int. 2016 May;89(5):1037-1048. doi: 10.1016/j.kint.2016.01.013. Epub 2016 Mar 11.

PMID:
27083281
12.

Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.

Potla U, Ni J, Vadaparampil J, Yang G, Leventhal JS, Campbell KN, Chuang PY, Morozov A, He JC, D'Agati VD, Klotman PE, Kaufman L.

J Clin Invest. 2014 Apr;124(4):1757-69. doi: 10.1172/JCI67846. Epub 2014 Mar 18.

13.

Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines.

Schiwek D, Endlich N, Holzman L, Holthöfer H, Kriz W, Endlich K.

Kidney Int. 2004 Jul;66(1):91-101.

14.

Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders.

Lasagni L, Ballerini L, Angelotti ML, Parente E, Sagrinati C, Mazzinghi B, Peired A, Ronconi E, Becherucci F, Bani D, Gacci M, Carini M, Lazzeri E, Romagnani P.

Stem Cells. 2010 Sep;28(9):1674-85. doi: 10.1002/stem.492.

15.

Cells of renin lineage take on a podocyte phenotype in aging nephropathy.

Pippin JW, Glenn ST, Krofft RD, Rusiniak ME, Alpers CE, Hudkins K, Duffield JS, Gross KW, Shankland SJ.

Am J Physiol Renal Physiol. 2014 May 15;306(10):F1198-209. doi: 10.1152/ajprenal.00699.2013. Epub 2014 Mar 19.

16.

MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.

Guo N, Guo J, Su D.

Ren Fail. 2016 Jul;38(6):989-95. doi: 10.3109/0886022X.2016.1165119. Epub 2016 Apr 8.

PMID:
27056206
17.

Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies.

Rodrigues PG, Bringhenti RN, do Nascimento JF, Joelsons G, dos Santos M, Pereira S, Veronese FV.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2185-98. eCollection 2014.

18.

Glucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms' tumor 1 (WT1).

Tsotakos NE, Sagnou M, Kotsopoulou ES, Tsilibary EC, Drossopoulou GI.

BMC Cell Biol. 2013 Jun 14;14:28. doi: 10.1186/1471-2121-14-28.

19.

De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.

Ohse T, Vaughan MR, Kopp JB, Krofft RD, Marshall CB, Chang AM, Hudkins KL, Alpers CE, Pippin JW, Shankland SJ.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F702-11. doi: 10.1152/ajprenal.00428.2009. Epub 2009 Dec 9.

20.

Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.

Hodgin JB, Bitzer M, Wickman L, Afshinnia F, Wang SQ, O'Connor C, Yang Y, Meadowbrooke C, Chowdhury M, Kikuchi M, Wiggins JE, Wiggins RC.

J Am Soc Nephrol. 2015 Dec;26(12):3162-78. doi: 10.1681/ASN.2014080752. Epub 2015 Jun 2.

Supplemental Content

Support Center